Come to meet us at Pharmapack on February 6th and 7th!

NEMERA NEWS

Come to meet us at Pharmapack on February 6th and 7th!

 

Pharmapack will take place in Paris, on February 6-7.

You can meet us at our booth C62, to meet our team and discover our latest innovative drug delivery devices:

  • Novelia®: our multidose eyedropper for preservative-free formulations. With Novelia®, 0% preservatives, 100% eye protection!
  • Safe’n’Sound®: our platform of fully passive safety devices for prefilled syringes to aid in the protection from accidental needlestick.
  • Safelia®: our new generation of 2-step autoinjectors for fluid or highly viscous formulations in 1ml and 2,25ml formats.
  • Advancia®: our new user-independent pump technology for nasal sprays.
  • SP270+: our high-performance and cost-effective pump for pharmaceutical sprays.
  • Sof’Bag®: our high performing airless pouch system for dermal and transdermal applications.
  • Sof’Airless XS and XL : our dermal package solutions suitable for liquid and viscous formulations in a comprehensive range of doses.

 

Also, discover how our e-devices will improve patients’ lives.

 

On February 7th, our Global Category Manager for ENT segment, Pascale Farjas will present the subject “How can devices improve compliance for nasal delivery treatment?”
Don’t miss her presentation at 13:50.

 


About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera’s services and products cover several key delivery routes: Nasal/Buccal/Auricular (spray pumps, actuators, valves, etc.), Ophthalmic (preservative-free multidose eyedroppers), Pulmonary (pMDI, MDI’s, DPI’s), Dermal /Transdermal (airless & atmospheric dispensers), and Parenteral (autoinjectors, pens, and safety devices).

Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer IP manufacturing.
.